Weakly supervised annotation‐free cancer detection and prediction of genotype in routine histopathology
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Deep learning is a powerful tool in computational pathology: it can be used for tumor detection and for predicting genetic alterations based on histopathology images alone. Conventionally, tumor detection and prediction of genetic alterations are two separate workflows. Newer methods have combined them, but require complex, manually engineered computational pipelines, restricting reproducibility and robustness. To address these issues, we present a new method for simultaneous tumor detection and prediction of genetic alterations: The Slide‐Level Assessment Model (SLAM) uses a single off‐the‐shelf neural network to predict molecular alterations directly from routine pathology slides without any manual annotations, improving upon previous methods by automatically excluding normal and non‐informative tissue regions. SLAM requires only standard programming libraries and is conceptually simpler than previous approaches. We have extensively validated SLAM for clinically relevant tasks using two large multicentric cohorts of colorectal cancer patients, Darmkrebs: Chancen der Verhütung durch Screening (DACHS) from Germany and Yorkshire Cancer Research Bowel Cancer Improvement Programme (YCR‐BCIP) from the UK. We show that SLAM yields reliable slide‐level classification of tumor presence with an area under the receiver operating curve (AUROC) of 0.980 (confidence interval 0.975, 0.984; n = 2,297 tumor and n = 1,281 normal slides). In addition, SLAM can detect microsatellite instability (MSI)/mismatch repair deficiency (dMMR) or microsatellite stability/mismatch repair proficiency with an AUROC of 0.909 (0.888, 0.929; n = 2,039 patients) and BRAF mutational status with an AUROC of 0.821 (0.786, 0.852; n = 2,075 patients). The improvement with respect to previous methods was validated in a large external testing cohort in which MSI/dMMR status was detected with an AUROC of 0.900 (0.864, 0.931; n = 805 patients). In addition, SLAM provides human‐interpretable visualization maps, enabling the analysis of multiplexed network predictions by human experts. In summary, SLAM is a new simple and powerful method for computational pathology that could be applied to multiple disease contexts. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ShuffleNet: An Extremely Efficient Convolutional Neural Network for Mobile Devices
Zhang, X., Zhou, X., Lin, M., & Sun, J. (2017) · arXiv · doi:10.48550/arxiv.1707.01083 · Cited by 9,982
ShuffleNet: An Extremely Efficient Convolutional Neural Network for Mobile Devices
Zhang, X., Zhou, X., Lin, M., & Sun, J. (2018) · 2018 IEEE/CVF Conference on Computer Vision and Pattern Recognition · doi:10.1109/cvpr.2018.00716 · Cited by 9,982
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer
André, T., Shiu, K.-K., Kim, T. W., Jensen, B. V., Jensen, L. H., Punt, C., Smith, D., Garcia-Carbonero, R., Benavides, M., Gibbs, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2017699 · Cited by 3,099 · cited 2×
“We applied SLAM to multiple clinically relevant target features in CRC: MSI/dMMR status (which quali fi es patients for immunotherapy [4]), BRAF mutational status (which quali fi es patients for targeted therapy [6]), and grade of differentiation (an established histopathology feature de fi ned on a…”
BackgroundMethodCoudray, N., Ocampo, P. S., Sakellaropoulos, T., Narula, N., Snuderl, M., Fenyö, D., Moreira, A. L., Razavian, N., & Tsirigos, A. (2018) · Nature Medicine · doi:10.1038/s41591-018-0177-5 · Cited by 2,930 · cited 3×
“The central hypothesis to this approach is that the genotype gives rise to the phenotype, therefore genetic changes cause phenotypic changes and deep learning can infer the genotype of tumors just by observing tissue phenotype [22].”
BackgroundMethodResultClinical-grade computational pathology using weakly supervised deep learning on whole slide images
Campanella, G., Hanna, M. G., Geneslaw, L., Miraflor, A., Werneck Krauss Silva, V., Busam, K. J., Brogi, E., Reuter, V. E., Klimstra, D. S., & Fuchs, T. J. (2019) · Nature Medicine · doi:10.1038/s41591-019-0508-1 · Cited by 2,799
Data-efficient and weakly supervised computational pathology on whole-slide images
Lu, M. Y., Williamson, D. F. K., Chen, T. Y., Chen, R. J., Barbieri, M., & Mahmood, F. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00682-w · Cited by 2,282
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
Kopetz, S., Grothey, A., Yaeger, R., Van Cutsem, E., Desai, J., Yoshino, T., Wasan, H., Ciardiello, F., Loupakis, F., Hong, Y. S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908075 · Cited by 1,491 · cited 2×
“…SLAM to multiple clinically relevant target features in CRC: MSI/dMMR status (which quali fi es patients for immunotherapy [4]), BRAF mutational status (which quali fi es patients for targeted therapy [6]), and grade of differentiation (an established histopathology feature de fi ned on a case level).”
BackgroundA method for normalizing histology slides for quantitative analysis
Macenko, M., Niethammer, M., Marron, J. S., Borland, D., Woosley, J. T., Guan, X., Schmitt, C., & Thomas, N. E. (2009) · 2009 IEEE International Symposium on Biomedical Imaging: From Nano to Macro · doi:10.1109/isbi.2009.5193250 · Cited by 1,482 · cited 1×
“…the bias of different staining procedures, all tiles were normalized based on one reference image using the Macenko normalization method using a reference image that is publicly available at: https://raw.githubusercontent.com/jnkather/ DeepHistology/master/subroutines_normalization/Ref. png[34].”
MethodKather, J. N., Pearson, A. T., Halama, N., Jäger, D., Krause, J., Loosen, S. H., Marx, A., Boor, P., Tacke, F., Neumann, U. P., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0462-y · Cited by 1,458
Self-citationDeep learning in cancer pathology: a new generation of clinical biomarkers
Echle, A., Rindtorff, N. T., Brinker, T. J., Luedde, T., Pearson, A. T., & Kather, J. N. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01122-x · Cited by 667 · cited 4×
“The application of such methods is not limited to CRC but has been demonstrated in bladder cancer [15], breast cancer [16,17], sarcoma [18], head and neck cancer [19], hepatocellular carcinoma [20], and several other types of solid tumor [8,12].”
BackgroundInfluentialSelf-citation
Cited by
Artificial intelligence in histopathology: enhancing cancer research and clinical oncology
Shmatko, A., Ghaffari Laleh, N., Gerstung, M., & Kather, J. N. (2022) · Nature Cancer · doi:10.1038/s43018-022-00436-4 · Cited by 446
“Although prediction performance did not reach clinical standards, this work provided seminal proof of principle and gave rise to follow-up studies on a number of solid tumor types, including breast cancer 73 , prostate cancer 74 and gastro-intestinal tumors 61,75,76 .”
MethodResultSelf-citationMcGenity, C., Clarke, E. L., Jennings, C., Matthews, G., Cartlidge, C., Freduah-Agyemang, H., Stocken, D. D., & Treanor, D. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01106-8 · Cited by 290
Wagner, S. J., Reisenbüchler, D., West, N. P., Niehues, J. M., Zhu, J., Foersch, S., Veldhuizen, G. P., Quirke, P., Grabsch, H. I., van den Brandt, P. A., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.08.002 · Cited by 275
Self-citationSwarm learning for decentralized artificial intelligence in cancer histopathology
Saldanha, O. L., Quirke, P., West, N. P., James, J. A., Loughrey, M. B., Grabsch, H. I., Salto-Tellez, M., Alwers, E., Cifci, D., Ghaffari Laleh, N., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01768-5 · Cited by 227
Self-citationKhader, F., Müller-Franzes, G., Wang, T., Han, T., Tayebi Arasteh, S., Haarburger, C., Stegmaier, J., Bressem, K., Kuhl, C., Nebelung, S., et al. (2023) · Radiology · doi:10.1148/radiol.230806 · Cited by 107
Self-citation
Metadata
- Authors
- Schrammen, P. L., Ghaffari Laleh, N., Echle, A., Truhn, D., Schulz, V., Brinker, T. J., Brenner, H., Chang‐Claude, J., Alwers, E., Brobeil, A., Kloor, M., Heij, L. R., Jäger, D., Trautwein, C., Grabsch, H. I., Quirke, P., West, N. P., Hoffmeister, M., & Kather, J. N.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2021-10-22
- Volume
- 256
- Issue
- 1
- Pages
- 50-60
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W3201366746
- Cited by
- 80
- References
- 18
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Weakly supervised annotation‐free cancer detection and prediction of genotype in routine histopathology. https://app.cochat.ai/papers/10.1002/path.5800
- The paper
- Schrammen, P. L., Ghaffari Laleh, N., Echle, A., Truhn, D., Schulz, V., Brinker, T. J., Brenner, H., Chang‐Claude, J., Alwers, E., Brobeil, A., Kloor, M., Heij, L. R., Jäger, D., Trautwein, C., Grabsch, H. I., Quirke, P., West, N. P., Hoffmeister, M., & Kather, J. N. (2022). Weakly supervised annotation‐free cancer detection and prediction of genotype in routine histopathology. The Journal of Pathology. https://doi.org/10.1002/path.5800
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.